Mixed connective tissue disease

Internal Medicine

Volumn 38, Issue 5, 1999, Pages 386-393

  Kasukawa, Reiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti U1snRNP antibody; Diagnostic criteria; HLA DR4; Pulmonary hypertension

Indexed keywords

AUTOANTIBODY; HLA DR4 ANTIGEN; SMALL NUCLEAR RIBONUCLEOPROTEIN;

CLASSIFICATION; HUMAN; IMMUNOLOGY; MIXED CONNECTIVE TISSUE DISEASE; MORTALITY; PULMONARY HYPERTENSION; REVIEW;

AUTOANTIBODIES; HLA-DR4 ANTIGEN; HUMANS; HYPERTENSION, PULMONARY; MIXED CONNECTIVE TISSUE DISEASE; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR;

EID: 0033127013     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.386     Document Type: Review

References (64)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148-159, 1972.
2. Reichlin M, Mattioli M. Correlation of a precipitin reaction to an RNA protein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med 286: 908-911, 1972.
3. Reichlin M. Problems in differentiating of SLE and mixed connective tissue disease. N Engl J Med 295: 1194-1195, 1976 (editorial).
4. Bennett RM, O'Connell DJ. Mixed connective tissue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum 10: 25-51, 1980.
5. LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 23: 341-343, 1980.
6. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 59: 239-248, 1980.
7. Lemmer JP, Curry NH, Mallory JH, Waller MV. Clinical characteristics and course of patients with high titer of anti-RNP antibodies. J Rheumatol 9: 536-542, 1982.
8. Black C, Isenberg DA. Mixed connective tissue disease. - goodbye to all that. Br J Rheumatol 31: 695-700, 1992 (see comments).
9. Isenberg DA. Mixed connective tissue disease. The case against. in: The Proceedings of ILAR Congress Singapore, 1997: 509-511 (Abstract).
10. Alarcón-Segovia D. Symptomatic Sjögren's syndrome in mixed connective tissue disease. J Rheumatol 3: 191-195, 1976.
11. Kasukawa R, Sharp GC. Mixed Connective Tissue Diseases and Antinuclear Antibodies. Elsevier, Amsterdam, 1987.
12. Alarcón-Segovia D, Villarreal M. Classification and diagnostic criteria for mixed connective tissue disease. in: Mixed Connective Tissue Diseases and Antinuclear Antibodies. Kasukawa R, Sharp GC, Eds. Elsevier, Amsterdam, 1987: 33-40.
13. Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies: a prospective study of 32 patients. J Rheumatol 18: 1511-1519, 1991 (see comments).
14. Hameenkorpi R, Ruuska P, Forsberg S, Tiilikainen R, Makitalo R, Hakala M. More evidence of distinctive features of mixed connective tissue disease. Scand J Rheumatol 22: 63-68, 1993.
15. Venables PJ. Undifferentiated connective tissue diseases: mixed or muddled? Lupus 7: 73-74, 1998 (editorial; comment).
16. Smolen JS, Steiner G. Mixed connective tissue disease: to be or not to be? Arthritis Rheum 41: 768-777, 1998.
17. Sharp GC. Diagnostic criteria for classification of MCTD. in: Mixed Connective Tissue Diseases and Antinuclear Antibodies. Kasukawa R, Sharp GC, Eds. Elsevier, Amsterdam, 1987: 23-32.
18. Kasukawa R, Tojo T, Miyawaki S, et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. in: Mixed Connective Tissue Diseases and Antinuclear Antibodies. Kasukawa R, Sharp GC, Eds. Elsevier, Amsterdam, 1987: 41-47.
19. Alarcón-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16: 328-334, 1989.
20. Doria A, Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol 19: 259-264, 1992.
21. Amigues JM, Cantagrel A, Abbal M, Mazieres B, and the Autoimmunity Group of the Hospitals of Toulouse. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. J Rheumatol 23: 2055-2062, 1996 (see comments).
22. Kahn MF, Appelboom T. Syndrome de Sharp. in: Les maladies systémiques. 3rd ed. Kahn MF, Peltier AP, Meyer O, Piette JC, Eds. Flammarion, Paris, 1991: 545-556.
23. + lymphocyte subsets in patients with mixed connective tissue disease. Clin Exp Immunol 88: 91-95, 1992.
24. Wiemann C, Bodenbach L, Pyerin W. Antibodies to casein kinase II in sera of patients with mixed connective tissue disease: evaluation with recombinant proteins. Clin Chem 39: 2492-2494, 1993.
25. Dong RP. Kimura A, Hashimoto H, Akizuki M, Nishimura Y, Sasazuki T. Difference in HLA-linked genetic background between mixed connective tissue disease and systemic lupus erythematosus. Tissue Antigens 41: 20-25, 1993.
26. Edwards JM, Porter JM. Raynaud's syndrome and small vessel arteriopathy. Semin Vasc Surg 6: 56-65, 1993.
27. 1-70 kda autoantibody positive patients with mixed connective tissue disease. J Rheumatol 24: 319-322, 1997 (see comments).
28. Ruuska P, Hameenkorpi R, Forsberg S, et al. Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus. Ann Rheum Dis 51: 52-55, 1992.
29. Ranki A, Kurki P, Riepponen S, Stephansson E. Antibodies to retroviral proteins in autoimmune connective tissue disease. Relation to clinical manifestations and ribonucleoprotein autoantibodies. Arthritis Rheum 35: 1483-1491, 1992.
30. Hassfeld W, Steiner G, Studnicka-Benke A, et al. Autoimmune response to the spliceosome: an immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum 38: 777-785, 1995.
31. Skriner K, Sommergruber WH, Tremmel V, et al. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex: differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus and mixed connective tissue disease. J Clin Invest 100: 127-135, 1997.
32. Tiddens HA, van der Net JJ, de Graeff-Meeder ER, et al. Juvenile-onset mixed connective tissue disease: longitudinal follow-up. J Pediatr 122: 191-197, 1993.
33. Yokota S. Mixed connective tissue disease in childhood. Acta Paediatr Jpn 35: 472-479, 1993.
34. 1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD). Clin Exp Immunol 98: 427-433, 1994.
35. Ozawa T, Ninomiya Y, Honma T, et al. Increased serum angiotensin-I converting enzyme activity in patients with mixed connective tissue disease and pulmonary hypertension. Scand J Rheumatol 24: 38-43, 1995.
36. 1) RNP antibodies in mixed connective tissue disease. Rheumatol Int 16: 145-150, 1996.
37. Mier R, Ansell B, Hall MA, et al. Long term follow-up of children with mixed connective tissue disease. Lupus 5: 221-226, 1996.
38. Kotajima L, Aotsuka S, Sumiya M, Yokohari R, Tojo T, Kasukawa R. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J Rheumatol 23: 1088-1094, 1996.
39. Magro CM, Crowson AN, Regauer S. Mixed connective tissue disease. A clinical, histologic, and immunofluorescence study of eight cases. Am J Dermatopathol 19: 206-213, 1997.
40. Maddison PJ. Overlap syndrome and mixed connective tissue disease. Curr Opin Rheumatol 3: 995-1000, 1991.
41. 1) snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients. Br J Rheumatol 31: 811-817, 1992.
42. Mairesse N, Kahn MF, Appelboom T. Antibodies to the constitutive 73-kd heat shock protein: A new marker of mixed connective tissue disease? Am J Med 95: 595-600, 1993.
43. Filep JG, Bodolay E, Sipka S, Gyimesi E, Csipö I, Szegedi G. Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease. Circulation 92: 2969-2974, 1995.
44. Garcia-de la Torre I, Salazar-Páramo M, Salmón-de la Torre G. Mixed connective tissue disease. A clinicoserological study of 17 cases. Mol Biol Rep 23: 153-157, 1996.
45. Michels H. Course of connective tissue disease in children. Ann Med 29: 359-364, 1997.
46. Lerner MR, Steitz JA. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 76: 5495-5499, 1979.
47. Alarcón-Segovia D, Ruiz-Arguelles A, Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 271: 67-69, 1978.
48. Deng JS, Ballou B, Hofmeister JK. Internalization of anti-nucleolin antibody into viable HEp-2 cells. Mol Biol Rep 23: 191-195, 1996.
49. Weisbart RH, Stempniak M, Harris S, Zach DJ, Ferreri K. An autoantibody system to target the cell nucleus: Therapeutic implication. Arthritis Rheum 41 (Suppl): S80, 1998 (Abstract).
50. 1-small nuclear ribonucleoprolein A protein in autoimmune disease patients. J Immunol 151: 1108-1115, 1993.
51. Okubo M, Kurokawa M, Ohto H, et al. Clonotype analysis of peripheral blood T cells and autoantigen-reactive T cells from patients with mixed connective tissue disease. J Immunol 153: 3784-3790, 1994.
52. Ikäheimo IL, Tiilikainen AS, Hameenkorpi R, Silvennoinen-Kassinen SH. Different distribution of T cell receptor beta-chain haplotypes in mixed connective tissue disease and systemic lupus erythematosus. Ann Med 26: 129-132, 1994.
53. gag antigen. Cell 51: 211-220, 1987.
54. 1) small nuclear RNP-specific 68-kd protein. - Expression in Escherichia coli and serodiagnostic application - . Arthritis Rheum 31: 616-622, 1988.
55. Fritzler MJ, Ali R, Tan EM. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hn RNP/RNA) of the nuclear matrix. J Immunol 132: 1216-1222, 1984.
56. Wiemann C, Bodenbach L, Pyerin W. Antibodies to casein kinase II in sera of patients with mixed connective tissue disease: Evaluation with recombinant protein. Clin Chem 39: 2492-2494, 1993.
57. Bodolay E, Bojan F, Szegedi G, Stenszky V, Farid NR. Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunol Lett 20: 163-167, 1989.
58. Gendi NS, Welsh KI, van Venrooij WJ, Vancheeswaran R, Gilroy J, Black CM. HLA type as a predictor of mixed connective tissue disease differentiation: ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum 38: 259-266, 1995.
59. Sawai T, Murakami K, Kasukawa R, Kyogoku M. Histopathological study of mixed connective tissue disease for 32 autopsy cases in Japan. Jpn J Rheumatol 7: 279-292, 1997.
60. Tojo T, Ogasawara T, Aotsuka S, Yokohari R. Major causes of death and five year survival rates in mixed connective tissue disease. 1990 Annual Report of The Research Committee of Japanese Ministry of Health and Welfare for Mixed Connective Tissue Disease. Yokohari R, Ed., 1991: 10-13 (in Japanese, Abstract in English).
61. Ichikawa Y, Tsunematsu T, Yokohari R, et al. Multicenter study of causes of death in systemic lupus erythematosus - a report from the Subcommittee for Development of Therapy, the Research Committee for Autoimmune Diseases Supported by the Ministry of Health and Welfare - . Ryumachi 25:258-264, 1985 (in Japanese, Abstract in English).
62. Kaburaki J, Lee CC, Ogasawara T, Okano H, Tojo T. Clinical study of progressive systemic sclerosis (PSS) patients with poor prognosis. Annual Report of the Ministry of Health and Welfare Scleroderma Research Committee 1988: 314-318 (in Japanese, Summary in English).
63. Esther JH, Sharp GH, Agia G, Hurst DJ, Maricq HR. Pulmonary hypertension in a patient with connective tissue disease and antibody to nuclear ribonucleoprotein. Arthritis Rheum 24: 2105, 1981 (Abstract).
64. Miyawaki S, Onodera H, Kasukawa R, Nishimaki T. Multicenter study on therapy and prognosis of mixed connective tissue disease. in: Proceedings of The Symposium on Therapy, Disease Type and Pulmonary Hypertension of Mixed Connective Tissue Disease. Research Committee of The Japanese Ministry of Health and Welfare for Mixed Connective Tissue Disease. Kasukawa R, Ed., 1991: 26-35 (in Japanese).